BiotechTube

Testosterone Undeconate (Nebido-R, BAY86-5037)

Pre-clinicalCompleted
0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hypogonadism

Conditions

Hypogonadism

Trial Timeline

Jun 1, 2007 → Oct 1, 2008

NCT ID
NCT00847314

About Testosterone Undeconate (Nebido-R, BAY86-5037)

Testosterone Undeconate (Nebido-R, BAY86-5037) is a pre-clinical stage product being developed by Bayer for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT00847314. Target conditions include Hypogonadism.

What happened to similar drugs?

6 of 19 similar drugs in Hypogonadism were approved

Approved (6) Terminated (3) Active (12)
✅Topical Testosterone SolutionEli LillyApproved
✅AndroGel® + PlaceboAbbVieApproved
✅AndroGel 1.62%AbbVieApproved
✅Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
✅NEBIDO + PLACEBOBayerApproved
✅JatenzoICON plc.Approved
🔄Testosterone Solution + Placebo SolutionEli LillyPhase 3

Hype Score Breakdown

Clinical
3
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT00847314Pre-clinicalCompleted
NCT00838838Pre-clinicalCompleted

Competing Products

20 competing products in Hypogonadism

See all competitors
ProductCompanyStageHype Score
Topical Testosterone SolutionEli LillyApproved
43
Testosterone Solution + Placebo SolutionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 2
35
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone MD-LotionEli LillyPhase 3
40
Testosterone Gel 1.62% + Testosterone Gel 1.62%AbbViePhase 1
29
ABT-SLV176AbbViePhase 3
32
AndroGel® + PlaceboAbbVieApproved
43
AndroGel 1.62%AbbVieApproved
43
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)MerckPhase 3
40
Oral testosterone undecanoate (Andriol) + PlaceboMerckPhase 2
35
Reference: Follitropin alfa + ZoladexMerckPhase 1
29
Testosterone + Alendronate + Placebo Alendronate + Placebo TestosteroneMerckPhase 2
27
Testosterone Enanthate + FinasterideMerckPhase 2
35
Testim 1% (testosterone gel) + PlaceboMerckPhase 2
27
Investigational new drug company code: BGS649 + PlaceboNovartisPhase 2
27
Test formulation + Reference formulationPfizerPhase 1
29
Testosterone ProductBayerPre-clinical
23
Testosterone undecanoate (TU) - NebidoTMBayerPhase 3
37
Testosterone Undeconate (Nebido, BAY86-5037) + PlaceboBayerApproved
32